JPY 2665.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 1.55 Billion | -1.24 Billion | -573 Million | 3.11 Billion | 247 Million |
Net Income | 417 Million | 300 Million | 60 Million | 766 Million | 188 Million |
Depreciation & Amortization | 67 Million | 69 Million | 72 Million | 72 Million | 75 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 641 Million | -1.57 Billion | -129 Million | 2.31 Billion | -227 Million |
Other non-cash items | 443 Million | -253 Million | -277 Million | 29 Million | 767 Million |
Investing Cash Flow | 679 Million | -454 Million | 434 Million | 145 Million | 374 Million |
Investments in PPE | -123 Million | -48 Million | -243 Million | -75 Million | -27 Million |
Acquisitions | 4 Million | 14 Million | 4 Million | 5 Million | 7 Million |
Investment purchases | - | -1.71 Billion | -201 Million | -704 Million | - |
Sales/Maturities of investments | 800 Million | 1.3 Billion | 852 Million | 933 Million | 392 Million |
Other Investing Activities | 5 Million | 9 Million | 35 Million | 2 Million | 2 Million |
Financing Cash Flow | -110 Million | -111 Million | -108 Million | -3.01 Billion | -138 Million |
Debt repayment | -2 Million | -2 Million | - | - | - |
Dividends payments | -107 Million | -108 Million | -108 Million | -137 Million | -137 Million |
Common Stock Repurchased | - | - | -1 Million | -2.87 Billion | -1 Million |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | -1 Million | -1 Million | 1 Million | - | - |
Accounts receivables | 201 Million | -1.55 Billion | -428 Million | 3 Billion | -864 Million |
Accounts payables | 367 Million | -26 Million | 327 Million | -943 Million | 569 Million |
Inventory | 51 Million | 47 Million | -116 Million | 171 Million | -111 Million |
Other working capital | 643 Million | -274 Million | -2 Million | 117 Million | 179 Million |
Cash at beginning of period | 6.42 Billion | 8.23 Billion | 8.47 Billion | 8.23 Billion | 7.75 Billion |
Cash at end of period | 8.54 Billion | 6.42 Billion | 8.23 Billion | 8.47 Billion | 8.23 Billion |
Capital Expenditure | -123 Million | -48 Million | -243 Million | -75 Million | -27 Million |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | 2.12 Billion | -1.81 Billion | -246 Million | 246 Million | 483 Million |
Free Cash Flow | 1.42 Billion | -1.29 Billion | -816 Million | 3.03 Billion | 220 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 27 Million | 242 Million | 417 Million | 89 Million | 90 Million | -11 Million |
Depreciation & Amortization | - | - | 67 Million | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 641 Million | - | - | - |
Other non-cash items | -27 Million | -242 Million | 443 Million | -89 Million | -90 Million | 11 Million |
Investing Cash Flow | - | - | 679 Million | - | - | - |
Investments in PPE | - | - | -123 Million | - | - | - |
Acquisitions | - | - | 4 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | 800 Million | - | - | - |
Other Investing Activities | - | - | 5 Million | - | - | - |
Financing Cash Flow | - | - | -110 Million | - | - | - |
Debt repayment | - | - | -2 Million | - | - | - |
Dividends payments | - | - | -107 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -1 Million | - | - | - |
Accounts receivables | - | - | 201 Million | - | - | - |
Accounts payables | - | - | 367 Million | - | - | - |
Inventory | - | - | 51 Million | - | - | - |
Other working capital | - | - | 643 Million | - | - | - |
Cash at beginning of period | - | - | 6.42 Billion | - | - | - |
Cash at end of period | - | - | 8.54 Billion | - | - | - |
Capital Expenditure | - | - | -123 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 2.12 Billion | - | - | - |
Free Cash Flow | - | - | 1.42 Billion | - | - | - |
SANGHVIMOV
ALKYLAMINE
LAURUSLABS
EVKRF
URLOF
GULFPETRO